Tarodyl
Tarodyl Brand names, Tarodyl Analogs
Tarodyl Brand Names Mixture
- No information avaliable
Tarodyl Chemical_Formula
C19H28NO3+
Tarodyl RX_link
http://www.rxlist.com/cgi/generic3/glycopyrrolate.htm
Tarodyl fda sheet
Tarodyl msds (material safety sheet)
Tarodyl Synthesis Reference
No information avaliable
Tarodyl Molecular Weight
318.431 g/mol
Tarodyl Melting Point
192.5 oC
Tarodyl H2O Solubility
No information avaliable
Tarodyl State
Solid
Tarodyl LogP
-0.99
Tarodyl Dosage Forms
Liquid; Tablet
Tarodyl Indication
For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.
Tarodyl Pharmacology
Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases the acidity of gastric secretions blocks cardiac vagal inhibitory reflexes during intubation
Tarodyl Absorption
Rapidly absorbed (1-2 minutes) after intravenous injection
Tarodyl side effects and Toxicity
Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral).
Tarodyl Patient Information
No information avaliable
Tarodyl Organisms Affected
Humans and other mammals
